Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 2921 Records) |
Query Trace: BRCA2[original query] |
---|
A chromosome-scale fishing cat reference genome for the evaluation of potential germline risk variants. Scientific reports 2024 4 14 (1): 8073. Rachel A Carroll, Edward S Rice, William J Murphy, Leslie A Lyons, Francoise Thibaud-Nissen, Lyndon M Coghill, William F Swanson, Karen A Terio, Tyler Boyd, Wesley C Warr |
Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review. Ecancermedicalscience 2024 4 18 1683. Fernanda J Martin, Isabel M Saffie, Mabel A Hurtado, Diana Avila-Jaque, Rodrigo A Lagos, Carolina A Selman, Jonathan Z Huserman, Valentina A Castillo, Badir J Chahu |
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype. JAMA network open 2024 4 7 (4): e247862. Giovanni Corso, Elena Marino, Cristina Zanzottera, Carla Oliveira, Loris Bernard, Debora Macis, Joana Figueiredo, Joana Pereira, Patrícia Carneiro, Giulia Massari, Massimo Barberis, Alessandra Margherita De Scalzi, Sergio Vincenzo Taormina, Elham Sajjadi, Claudia Sangalli, Sara Gandini, Oriana D'Ecclesiis, Cristina Maria Trovato, Anna Rotili, Filippo Pesapane, Luca Nicosia, Carlo La Vecchia, Viviana Galimberti, Elena Guerini-Rocco, Bernardo Bonanni, Paolo Verone |
Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology 2024 4 . In Hee Lee, Soo Jung Lee, Juhyung Kim, Yoon Hee Lee, Gun Oh Chong, Jong Mi Kim, Juhun Lee, Nan Young Lee, Seo Young Park, Dea Gy Hong, Yee Soo Ch |
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA network open 2024 4 7 (4): e247421. Zhenzhen Zhang, Shangyuan Ye, Sarah M Bernhardt, Heidi D Nelson, Ellen M Velie, Virginia F Borges, Emma R Woodward, D Gareth R Evans, Pepper J Sched |
Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System. BMC cancer 2024 4 24 (1): 499. Caroline de Oliveira Ferreira, Vandré Cabral Gomes Carneiro, Carolline Araujo Mar |
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. medRxiv : the preprint server for health sciences 2024 4 . Ed M Dicks, Jonthan P Tyrer, Suzana Ezquina, Michelle Jones, John Baierl, Pei-Chen Peng, Michael Diaz, Ellen Goode, Stacey J Winham, Thilo Dörk, Toon Van Gorp, Ana De Fazio, David Bowtell, Kunle Odunsi, Kirsten Moysich, Marina Pavanello, Ian Campbell, James D Brenton, Susan J Ramus, Simon A Gayther, Paul D P Pharo |
Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants. medRxiv : the preprint server for health sciences 2024 4 . Ryan D Chow, Ravi B Parikh, Katherine L Nathans |
Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ?50 years. Cancer 2024 4 . Rinat Bernstein-Molho, Narmeen Abu Shhada, Yael Laitman, Iris Netzer, Shelley Shoval, Eitan Friedm |
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Clinical laboratory 2024 4 70 (4): . Jin Ju Kim, Dong Ja Kim, Eon Jeong Nam, Kyung Eun Song, Ji Yeon Ham, Yu Kyung Kim, Nan Young L |
The Molecular Landscape of Gastric Cancers for Novel Targeted Therapies from Real-World Genomic Profiling. Targeted oncology 2024 4 . Hiroyuki Yamamoto, Hiroyuki Arai, Ritsuko Oikawa, Kumiko Umemoto, Hiroyuki Takeda, Takuro Mizukami, Yohei Kubota, Ayako Doi, Yoshiki Horie, Takashi Ogura, Naoki Izawa, Jay A Moore, Ethan S Sokol, Yu Sunaka |
Risk factors for ovarian cancer by BRCA status: a collaborative case-only analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 2 . Kate Gersekowski, Renhua Na, Kathryn Alsop, Rachel Delahunty, Ellen L Goode, Julie M Cunningham, Stacey J Winham, Paul D P Pharoah, Honglin Song, Penelope M We |
Genetic contribution of breast cancer genes in women of black African origin. Frontiers in genetics 2024 1 14 1302645. Rokhaya Ndiaye, Jean Pascal Demba Diop, Ahmadou Dem, Alioune Die |
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing Evidence. Clinical genitourinary cancer 2024 1 . Francesco Ditonno, Alberto Bianchi, Sarah Malandra, Antonio Benito Porcaro, Emanuela Fantinel, Riccardo Negrelli, Matteo Ferro, Michele Milella, Matteo Brunelli, Riccardo Autorino, Maria Angela Cerruto, Alessandro Veccia, Alessandro Antonel |
A MALDI-TOF mass spectrometry-based method for detection of copy number variations in BRCA1 and BRCA2 genes. Frontiers in molecular biosciences 2024 1 10 1301652. Hongjun Zhou, Xin He, Jiadong Zhao, Zhu Mei, Xiayan Zhang, Wen Yuan, Hui Do |
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice. JCO precision oncology 2024 1 8 e2300332. Eirini Papadopoulou, George Rigas, Elena Fountzilas, Anastasios Boutis, Stylianos Giassas, Nikolaos Mitsimponas, Danai Daliani, Dimitrios C Ziogas, Michalis Liontos, Vasileios Ramfidis, Charalampos Christophilakis, Dimitris Matthaios, Theofanis Floros, Chrysiida Florou-Chatzigiannidou, Konstantinos Agiannitopoulos, Angeliki Meintani, Aikaterini Tsantikidi, Anastasia Katseli, Kevisa Potska, Georgios Tsaousis, Vasiliki Metaxa-Mariatou, George Nasioul |
Investigation of Genetic Alterations Associated With Interval Breast Cancer. JAMA oncology 2024 1 . Juan Rodriguez, Felix Grassmann, Qingyang Xiao, Mikael Eriksson, Xinhe Mao, Svetlana Bajalica-Lagercrantz, Per Hall, Kamila Cze |
BRCA mutation status and pathological characterization of breast cancer in Zhoushan Islands, China. The Journal of international medical research 2024 1 52 (1): 3000605231223426. Shuhui Bao, Nini Sun, Yaling Li, Jiaojie Shu, Jing Xu, Yong Zhang, Xia Q |
Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Tomas Januskevicius, Ieva Vaicekauskaite, Rasa Sabaliauskaite, Augustinas Matulevicius, Alvydas Vezelis, Albertas Ulys, Sonata Jarmalaite, Feliksas Jankevici |
Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women. Genes 2024 1 15 (1): . Liliya Skvortsova, Saltanat Abdikerim, Kanagat Yergali, Natalya Mit, Anastassiya Perfilyeva, Nazgul Omarbayeva, Aigul Zhunussova, Zulfiya Kachiyeva, Tolkyn Sadykova, Bakhytzhan Bekmanov, Dilyara Kaidarova, Leyla Djansugurova, Gulnur Zhunusso |
Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 2024 1 . Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Lingying Wu, Hongwen Y |
Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer. International journal of general medicine 2024 1 17 75-84. Yu Luo, Ru Pan, Hui Rao, Xing Chen, Haikun Ya |
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments. BMC cancer 2024 1 24 (1): 85. Mirai Ido, Kimihito Fujii, Hideyuki Mishima, Akihito Kubo, Masayuki Saito, Hirona Banno, Yukie Ito, Manami Goto, Takahito Ando, Yukako Mouri, Junko Kousaka, Tsuneo Imai, Shogo Naka |
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review. International medical case reports journal 2024 1 17 23-29. Yang Liu, Hui Yang, Xueshu Fu, Luting Zhong, Ping Xu, Fang Fang, Ying Liu, Qing Li, Ya'nan Yan, Shanchuang Wei, Junqing Wang, Chunhua Zha |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
Counselling and management of women with genetic predisposition to gynaecological cancers. European journal of obstetrics, gynecology, and reproductive biology 2024 1 294 44-48. Naushabah Malik, Banchhita Sa |
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction. Cancers 2024 1 16 (1): . Dimitrios C Ziogas, Eirini Papadopoulou, Helen Gogas, Stratigoula Sakellariou, Evangellos Felekouras, Charalampos Theocharopoulos, Dimitra T Stefanou, Maria Theochari, Ioannis Boukovinas, Dimitris Matthaios, Anna Koumarianou, Eleni Zairi, Michalis Liontos, Konstantinos Koutsoukos, Vasiliki Metaxa-Mariatou, George Kapetsis, Angeliki Meintani, Georgios N Tsaousis, George Nasioul |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: